Journals / Türk Nöroloji Dergisi / 2008 / Cilt: 14 - Sayı: 5

Intracranial involvement of multiple myeloma

Multipl myelomda intrakranial tutulum

Pages
328–332
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The occurrence of neurological symptoms in a patient with myeloma requires an accurate evaluation with MR and lumbar puncture to detect a possible meningeal or cerebral involvement, when metabolic factors (hypercalcemia,drug toxicity, uremia), hyperviscosity, or medullary compression can be excluded.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Multiple myeloma is usually restricted to the bone marrow.
📊
Key Findings & Data:Central nervous system involvement is uncommon and can be observed in approximately 1% of the multiple myeloma patients.
💡
Conclusion & Impact:The occurrence of neurological symptoms in a patient with myeloma requires an accurate evaluation with MR and lumbar puncture to detect a possible meningeal or cerebral involvement, when metabolic factors (hypercalcemia,drug toxicity, uremia), hyperviscosity, or medullary compression can be excluded.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Multiple myeloma is usually restricted to the bone marrow. Central nervous system involvement is uncommon and can be observed in approximately 1% of the multiple myeloma patients. OBJECTIVES: We aimed to demonstrate brain magnetic resonance patterns in patients with multiple myeloma with neurologic symptoms and the literature is reviewed. METHODS: We retrospectively studied 39 patients with multiple myeloma with neurologic symptoms. All the patients underwent classic and contrast enhanced brain MR examination. RESULTS: Patients presented with the following symptoms: impaired consciousness (n=8, 20.5%), headache (n=6, 15.3%), hemiparesis (n=2, 5.1%), aphasia (n=6, 15.3%), scalp swelling (n=2, 5.1%), visual loss (n=1, 2.5%), seizure (n=2, 5.1%), vertigo (n=4, 10.2%), ophthalmoplegia (n=4, 10.2%), meningeal irritation findings (n=2, 5.1%), and orientation disorder (n=2, 5.1%). Among 39 patients with multiple myeloma, 14 (35.8%) had ischemic lesions, 14 (35.8%) had calvarial diploic metastases, 5 (12.8%) had dura mater mass, 4 (10.2%) had dura mater involvement, 2 (5.1%) had sinonasal mass, 1 had cavernous sinus and orbital apex mass, 1 (2.5%) had leptomeningeal involvement, 1 (2.5%) had intraorbital mass, 3 (7.6%) had clivus mass, 1 (2.5%) had optic neuritis, 1 (2.5%) had central pontine myelinolysis and 2 (5.1%) had meningitis. Examination of the cerebrospinal fluid was performed in 6 patients. Cerebrospinal fluid studies showed malignant plasma cells in 1 patient with leptomeningeal contrast enhancement. Despite serial cerebrospinal fluid examination, plasma cells in cerebrospinal fluid were not showed in 2 patients with dura mater involvement. Two patients had menengitis. CONCLUSION: Involvement of the central nervous system in multiple myeloma is very uncommon. The occurrence of neurological symptoms in a patient with myeloma requires an accurate evaluation with MR and lumbar puncture to detect a possible meningeal or cerebral involvement, when metabolic factors (hypercalcemia,drug toxicity, uremia), hyperviscosity, or medullary compression can be excluded.

Özet

AMAÇ: Multipl myelom genellikle kemik iliğinde sınırlı kalmakta, nadiren ekstramedüller tutulumlar oluşturmaktadır. Santral sinir sistemi tutulumu oldukça nadir olup tüm multipl myelom olgularının %1'inde tanımlanmıştır. AMAÇLAR: Multipl myelomda santral sinir sistemi tutulumunun değerlendirilmesi ve literatürün gözden geçirilmesi amaçlanmıştır. YÖNTEMLER: Multipl myelom tanısı almış ve nörolojik yakınmaları nedeniyle beyin MR tetkiki yapılan 39 olgu geriye dönük olarak değerlendirildi. Tüm olgulardan rutin beyin MR incelemesine ilave olarak kontrastlı görüntüler alındı. Altı olguda BOS incelemesi gerçekleştirildi.BULGULAR: Olguların 8'i (%20.5) bilinç bozukluğu, 5'i (%12.8) konuşma bozukluğu, 6'sı (%15.3) başağrısı, 4'ü (%10.2) baş dönmesi, 4'ü (%10.2) oftalmopleji, 2'si (%5.1) hemiparezi, 2'si (%5.1) meningeal irritasyon bulguları, 2'si (%5.1) oryantasyon bozukluğu, 2'si (%5.1) skalpte şişlik, 2'si (%5.1) epilepsi ve 1'i (%2.5) görme bulanıklığı ile başvurdu. Kontrastlı beyin MR görüntülerde 14 olguda (%35.8) akut ve kronik iskemik lezyonlar, 14 olguda (%35.8) diploe lezyonu, 5 (%12.8) olguda kemik destrüksiyonuna eşlik eden dural kitle, 4 olguda (%10.2) dural kalınlaşma, 3 olguda (%7.6) klivus kitlesi, 2 olguda (%5.1) paranazal sinüs kitlesi, 2 olguda (%5.1) leptomeningeal tutulum, 1 olguda (%2.5) orbital apeks ve kavernoz sinüs tutulumu, 1 olguda (%2.5) optik sinirde kontrastlanma, 1 olguda (%2.5) intraorbital kitle ve 1 olguda (%2.5) pontin myelinolizis saptandı. iki olgunun (%5.1) beyin MR'ı normaldi. Dural kalınlaşma, leptomeningeal tutulum ve meningeal irritasyon bulguları olan 6 olguya lomber ponksiyon yapıldı. Leptomeningeal tutulumu olan olgunun BOS analizinde plazma hücresi tespit edilirken dural kalınlaşması olan olgularda tekrarlayan lomber ponksiyonlara rağmen hücre tespit edilmedi. BOS bulgularına dayanarak iki olguya bakteriyel menenjit tanısı kondu.SONUÇ: Multipl myelomda santral sinir sistemi tutulumu nadirdir. Metabolik (hiperkalsemi, ilaç toksisitesi, üremi) nedenler, hiperviskozite ve spinal kord kompresyonlarıyla açıklanamayan nörolojik bulgular varlığında santral sinir sistemi tutulumunun BOS analizi ve beyin MR tetkikiyle araştırılması uygun olacaktır.

🔖

Cite This Article

GİRAY, S., YERAL, M., KASAR, M., KIZILKILIÇ, E., ÖZDOĞU, H., ASMA, S., YILDIRIM, T., ALKAN, Ö., KIZILKILIÇ, O. (2022). Intracranial involvement of multiple myeloma. Türk Nöroloji Dergisi, Cilt: 14 - Sayı: 5, 328–332. https://ajindex.com/articles/637084

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Nieuwenhuizen L, Biesma DH. Central nervous system myelomatosis: review of the literature. Eur J Haematol. 2008;80:1-9
  2. Angtuaco EJ, Fassas AB, Walker R, Sethi R, Barlogie B. Multiple myeloma: clinical review and diagnostic imaging. Radiology. 2004;231:11-23
  3. Fassas AB, Muwalla F, Berryman T, Benramdane R, Joseph L, Anaissie E, Sethi R, Desikan R, Siegel D, Badros A, Toor A, Zangari M, Morris C, Angtuaco E, Mathew S, Wilson C, Hough A, Harik S, Barlogie B, Tricot G. Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations. Br J Haematol. 2002;117:103-8
  4. Petersen SL, Wagner A, Gimsing P.Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature. Am J Hematol. 1999;622: 28-33
  5. Schluterman KO, Fassas AB, Van Hemert RL, Harik SI.Multiple myeloma invasion of the central nervous system. Arch Neurol. 2004;61:1423-9
  6. Moran CC, Anderson CC, Caldemeyer KS, Smith RR. Meningeal myelomatosis: CT and MR appearances. AJNR Am J Neuroradiol. 1995;16:1501-3
  7. Haegelen C, Riffaud L, Bernard M, Carsin-Nicol B, Morandi X. Dural plasmacytoma revealing multiple myeloma. Case report. J Neurosurg. 2006;104:608-10
  8. Provenzale JM, Schaefer P, Traweek ST, Ferry J, Moore JO, Friedman AH, McLendon RE. Craniocerebral plasmacytoma: MR features. AJNR Am J Neuroradiol. 1997;18:389-92
  9. Roddie P, Collie D, Johnson P. Myelomatous involvement of the dura mater: a rare complication of multiple myeloma. J Clin Pathol. 2000;53:398-9
  10. Patriarca F, Zaja F, Silvestri F, Sperotto A, Scalise A, Gigli G, Fanin R. Meningeal and cerebral involvement in multiple myeloma patients. Ann Hematol. 2001;80:758-62
  11. Husain MM, Metzer WS, Binet EF. Multiple intraparenchymal brain plasmacytomas with spontaneous intratumoral hemorrhage. Neurosurgery. 1987;20:619-23
  12. Chamberlain MC, Glantz M. Myelomatous meningitis. Cancer. 2008;112:1562-7
  13. Yeung SN, Paton KE, Dorovini-Zis K, Chew JB, White VA. Histopathologic features of multiple myeloma involving the optic nerves. J Neuroophthalmol. 2008;28:12-6
  14. Bachar G, Goldstein D, Brown D, Tsang R, Lockwood G, Perez Ordonez B, Irish J. Solitary extramedullary plasmacytoma of the head and neck--long-term outcome analysis of 68 cases. Head Neck. 2008;30:1012-9
  15. Ortin X, Rodríguez-Luaces M, Calabuig M, Font L. Stroke in a multiple myeloma patient treated with thalidomide